{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T12:00:04Z","timestamp":1768910404508,"version":"3.49.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s13365-024-01213-y","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T21:01:36Z","timestamp":1716411696000},"page":"208-213","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Spinal cord involvement in progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome"],"prefix":"10.1007","volume":"30","author":[{"given":"Nisrine El","family":"Moussaoui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majdouline El","family":"Moussaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elettra","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"L\u00e9onard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Mo\u00efse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Maquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,22]]},"reference":[{"issue":"2","key":"1213_CR5","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/brain\/awab419","volume":"145","author":"LE Baldassari","year":"2022","unstructured":"Baldassari LE, Wattjes MP, Cortese ICM, Gass A, Metz I, Yousry T, Reich DS, Richert N (2022) The neuroradiology of progressive multifocal leukoencephalopathy: a clinical trial perspective. Brain 145(2):426\u2013440. https:\/\/doi.org\/10.1093\/brain\/awab419","journal-title":"Brain"},{"issue":"15","key":"1213_CR6","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1212\/WNL.0b013e31828c2fa1","volume":"80","author":"JR Berger","year":"2013","unstructured":"Berger JR, Aksamit AJ, Clifford DB, Davis L, Koralnik IJ, Sejvar JJ, Bartt R, Major EO, Nath A (2013) PML diagnostic criteria: Consensus statement from the AAN Neuroinfectious Disease Section. Neurology 80(15):1430\u20131438. https:\/\/doi.org\/10.1212\/WNL.0b013e31828c2fa1","journal-title":"Neurology"},{"issue":"1","key":"1213_CR10","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1212\/NXI.0000000000001097","volume":"9","author":"R Bernard-Valnet","year":"2022","unstructured":"Bernard-Valnet R, Moisset X, Maubeuge N, Lefebvre M, Ouallet JC, Roumier M, Lebrun-Frenay C, Ciron J, Biotti D, Clavelou P, Godeau B, Du Pasquier RA, Martin-Blondel G (2022) CCR5 blockade in inflammatory PML and PML-IRIS associated with chronic inflammatory diseases\u2019 treatments. Neurol Neuroimmunol Neuroinflamm 9(1):1097. https:\/\/doi.org\/10.1212\/NXI.0000000000001097","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"1213_CR7","doi-asserted-by":"publisher","unstructured":"Boster A, Hreha S, Berger JR, Bao F, Penmesta R, Tselis A, Endress C, Zak I, Perumal J, Caon C, Vazquez J, Tyler KL, Racke MK, Millis S, Khan O (2009) Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study. Arch Neurol 66(5). https:\/\/doi.org\/10.1001\/archneurol.2009.31","DOI":"10.1001\/archneurol.2009.31"},{"issue":"2","key":"1213_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/ana.26512","volume":"93","author":"X Boumaza","year":"2023","unstructured":"Boumaza X, Bonneau B, Roos-Weil D, Pinnetti C, Rauer S, Nitsch L, Del Bello A, Jelcic I, S\u00fchs KW, Gasnault J, Goreci Y, Grauer O, Gnanapavan S, Wicklein R, Lambert N, Perpoint T, Beudel M, Clifford D, Sommet A, Cortese I, Martin-Blondel G (2023) Progressive multifocal leukoencephalopathy treated by immune checkpoint inhibitors. Ann Neurol 93(2):257\u2013270. https:\/\/doi.org\/10.1002\/ana.26512","journal-title":"Ann Neurol"},{"issue":"1","key":"1213_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41582-020-00427-y","volume":"17","author":"I Cortese","year":"2021","unstructured":"Cortese I, Reich DS, Nath A (2021) Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease. Nat Rev Neurol 17(1):37\u201351. https:\/\/doi.org\/10.1038\/s41582-020-00427-y","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"1213_CR8","doi-asserted-by":"publisher","first-page":"3814","DOI":"10.1111\/ene.15021","volume":"28","author":"N Lambert","year":"2021","unstructured":"Lambert N, El Moussaoui M, Maquet P (2021) Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: identifying relevant outcome factors. Eur J Neurol 28(11):3814\u20133819. https:\/\/doi.org\/10.1111\/ene.15021","journal-title":"Eur J Neurol"},{"key":"1213_CR9","doi-asserted-by":"publisher","unstructured":"Lambert N, Dauby S, Dive D, Sadzot B, Maquet P (2022) Atezolizumab treatment for progressive multifocal leukoencephalopathy. Emerg Infect Dis 28(1). https:\/\/doi.org\/10.3201\/eid2801.204809","DOI":"10.3201\/eid2801.204809"},{"issue":"7","key":"1213_CR3","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.3390\/v15071510","volume":"15","author":"N Lambert","year":"2023","unstructured":"Lambert N, El Moussaoui M, Baron F, Maquet P, Darcis G (2023) Virus-specific T-Cell therapy for viral infections of the central nervous system. Rev Viruses 15(7):1510. https:\/\/doi.org\/10.3390\/v15071510","journal-title":"Rev Viruses"},{"issue":"3","key":"1213_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00401-015-1383-6","volume":"129","author":"G Martin-Blondel","year":"2015","unstructured":"Martin-Blondel G, Bauer J, Uro-Coste E, Biotti D, Averseng-Peaureaux D, Fabre N, Dumas H, Bonneville F, Lassmann H, Marchou B, Liblau RS, Brassat D (2015) Therapeutic use of CCR5 antagonists is supported by strong expression of CCR5 on CD8\u2009+\u2009T cells in progressive multifocal leukoencephalopathy-associated immune reconstitution inflammatory syndrome. Acta Neuropathol 129(3):463\u2013465. https:\/\/doi.org\/10.1007\/s00401-015-1383-6","journal-title":"Acta Neuropathol"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-024-01213-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13365-024-01213-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-024-01213-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T07:29:34Z","timestamp":1725348574000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13365-024-01213-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1213"],"URL":"https:\/\/doi.org\/10.1007\/s13365-024-01213-y","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"29 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was provided by the patient for her clinical course and images to be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}